Eiasi files market authorization for Alzheimer’s drug in Japan
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Drugs
Pharma
Drugs
Health
Pharma
Decade-long study pinpoints baffling causes of epilepsy in children
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure
Drugs
Medical
Pharma
UK’s AI stroke machine to cut treatment time by 60 mts
An artificial intelligence-powered machine can reduce the treatment time for stroke patients by 60 minutes and free up clinicians’ time.
Drugs
Health
AAP guidelines for obesity treatment in children call for early, intensive treatment
The American Academy of Pediatrics has issued guidelines advising aggressive treatment of obesity in children as young as 12.
Health
Medical
Stroke deaths may see a rise as millennials age, says study
A recent analysis shows that stroke fatalities will rise among millennials, as the age.
Drugs
Pharma
WHO issues medical product alert on Marion’s syrups
The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit
Health
Medical
Boiled peanuts could help overcome peanut allergy in children
Boiling peanuts for up to 12 hours can help children overcome any allergic reaction to this legume.
Drugs
Pharma
Insilico announces positive phase 1 trial results for AI-designed IPF drug
Insilico Medicine, an AI biotech company, announced positive results from the Phase 1 clinical trial of INS018_055, its first-in-class drug for idiopathic pulmonary fibrosis